Skip to main content
Clinical Trials/NCT02983929
NCT02983929
Completed
Not Applicable

Impact of Elevated Body Mass Index on Short-term Follow-up Indicators for Total Knee Arthroplasty : a Retrospective Study

Centre Hospitalier Durécu Lavoisier0 sites244 target enrollmentJanuary 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Total Knee Arthroplasty
Sponsor
Centre Hospitalier Durécu Lavoisier
Enrollment
244
Primary Endpoint
Body Mass Index
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The main purpose of this study is to determine the influence of obesity on the short term follow-up indicators of a polyvalent geriatric rehabilitation clinic after total knee arthroplasty. It is a retrospective, comparative study

The secondary purposes are to explore the links between length of stay and short-term follow-up indicators of a polyvalent geriatric rehabilitation clinic after total knee arthroplasty.

Registry
clinicaltrials.gov
Start Date
January 2007
End Date
November 2016
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Centre Hospitalier Durécu Lavoisier
Responsible Party
Principal Investigator
Principal Investigator

Timothée Gillot

Physical therapist, Msc.

Centre Hospitalier Durécu Lavoisier

Eligibility Criteria

Inclusion Criteria

  • Patient admitted after total knee arthroplasty in Polyvalent Geriatric Rehabilitation Clinic during the january 2007/October 2016 period

Exclusion Criteria

  • Uncompleted case file or case file anterior to 2007 ;
  • Inter-current orthopedic complication ;
  • Evolutive or inter-current pathology written in the case-file (neurologic affection, etc...).

Outcomes

Primary Outcomes

Body Mass Index

Time Frame: 2 Month

Range Of Motion of the Knee

Time Frame: 2 Month

The investigators will report the initial, final flexion and extension and calculate the total gain of flexion and extension of the knee for each participant.

Age

Time Frame: 2 Month

Mansat Score

Time Frame: 2 Month

This score is a composite score recommended by the French Authority of Health.

Secondary Outcomes

  • Length of stay(2 month)

Similar Trials